Guidelines for reducing the risk of viral transmission during fertility treatment.
These guidelines provide strategies, based on scientific principles and clinical experience, for reducing the risk of virus transmission in couples seeking treatment for infertility.
D052685:Alphapapillomavirus / Q000302:isolation & purification; D019411:Clinical Laboratory Techniques; D005260:Female; D006268:Health Facilities; D006287:Health Planning Guidelines; D006507:Hepatovirus / Q000302:isolation & purification; D015368:Human T-lymphotropic virus 1 / Q000302:isolation & purification; D015367:Human T-lymphotropic virus 2 / Q000302:isolation & purification; D006801:Humans; D007246:Infertility / Q000150:complications / Q000628:therapy* / Q000821:virology; D008297:Male; D011247:Pregnancy; D012307:Risk Factors; D040242:Risk Reduction Behavior; D015229:Sexually Transmitted Diseases, Viral / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control* / Q000635:transmission; D018139:Simplexvirus / Q000302:isolation & purification; D013094:Spermatozoa / Q000473:pathology / Q000821:virology